CK20-004, j. Craig venter insitute and cleveland VA prevention and intervention epicenter

Active Cooperative Agreement Awarded Last action

Award ID
U54CK000603
Recipient
Awarding agency
Obligated
$11,465,937

Award facts

Completion date 90% complete
Originally
Funding
  • $10,867,674.00 Federal
  • $598,263.00 Non-federal
Funding agency
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Rockville, MD, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $590,489 $0
Amendment $590,489 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $589,572 $0
Amendment $589,572 $0
Amendment $0 $0
Amendment $0 $0
Amendment $244,444 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $594,596 $0
Amendment $0 $0
Amendment $594,596 $0
Amendment $594,596 $0
Amendment $579,022 $0
Amendment -$579,022 $0
Amendment -$579,022 $0
Amendment $579,022 $0
Amendment $579,022 $0
Amendment $579,022 $0
Amendment $882,599 $0
Amendment $882,599 $0
Amendment $598,263 $0
Amendment $849,909 $0
Amendment $598,263 $598,263
Amendment $0 $0
Amendment $967,238 $0
Original award $542,405 $0
Show all 33

Subawards

Subrecipient Amount Awarded
University Of Maryland, College Park For the proposed project the Gonzalez-Juarbe Lab will execute an in vitro assessment of combinatorial phage, antimicrobial peptide and sub-MIC antibiotic… $42,793
Case Western Reserve University Case Western Reserve University will lead the Stenotrophomonas maltophilia complex components of Activities 2 and 3. For Activity 2, CWRU will curate and… $117,273
The Cleveland VA Medical Research & Education Foundation To achieve our overall project objective, we propose to conduct a natural history study of patients with C. auris colonization or infection in collaboration… $68,640
University Of Maryland, College Park For the proposed project the Consortium PI's lab will execute an in vivo assessment of phage therapy on clearing nasopharyngeal infections and effect on… $76,653
The Cleveland VA Medical Research & Education Foundation The protocol will be approved by the animal care committee of the Cleveland VA Medical Center. We will use an established mouse model to examine the… $30,000
Northwestern University End-stage heart failure is a major cause of morbidity and mortality in the United States. To provide mechanical circulatory support, left ventricular assist… $189,453
Northwestern University As Chicago is a locus of high prevalence, a program aiming for screening and isolating patients who are directly admitted from either a skilled nursing or… $150,000
Duke University Specific Aims (SA) 1, 2, and 3 rely on clinical data and bacterial specimens from patients with Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella… $461,991
Case Western Reserve University Stenotrophomonas maltophilia (Sma) is an important nosocomial pathogen with mortality rates ranging from 14 to 69% in patients with bacteremia. Sma prevalence… $1,458,328

Quick answers

Who received award U54CK000603?

U54CK000603 was awarded to J. Craig Venter Institute, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on June 1, 2021.

How much is award U54CK000603 worth?

$11,465,937 has been obligated on U54CK000603: $10,867,674 in federal funding and $598,263 in non-federal funding.

Which agency awarded U54CK000603?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded U54CK000603, with funding from National Center for Emerging and Zoonotic Infectious Diseases (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login